A Comprehensive Proteomic Map of Mammalian Mitochondria

哺乳动物线粒体的综合蛋白质组图谱

基本信息

项目摘要

DESCRIPTION (provided by applicant): Mitochondria are tiny organelles found within virtually all of our body's cells. They control a number of important cellular processes, including energy production, fat metabolism, steroid synthesis, and programmed cell death. Recently, multiple studies have shown that inherited or acquired mitochondrial dysfunction can give rise to a host of rare metabolic disorders, as well as many common diseases, including type 2 diabetes mellitus, heart failure, neurodegeneration, and the aging process itself. Mitochondria are complex structures, consisting of an estimated 1500 proteins. The majority of these proteins are encoded in the cell's nucleus, produced in the cytosol, and then imported into the mitochondrion. At present, we only know about 750 of the estimated 1500 mitochondrial proteins. Because mitochondria contribute to so many rare and common human diseases, it's important that we systematically identify all the proteins that constitute this organelle and begin to understand how they function together in health and in disease. Availability of complete mammalian genome sequences, in combination with new protein detection and microscopy technologies, now provide a special opportunity to systematically and comprehensively identify all the protein components of mammalian mitochondria, as well as how they function together. In the current application, we propose to use a multidisciplinary approach that blends protein biochemistry, computational genomics, and imaging, to construct a protein parts list for mammalian mitochondria. This project will provide an important foundation for systematic approaches to mitochondrial function, which will be extremely important in the coming years as we link its activity to common human diseases, such as type 2 diabetes mellitus. Moreover, the protein catalog that we generate will immediately provide a rich source of candidate disease genes for rare mitochondrial disorders.
描述(由申请人提供):线粒体是几乎存在于我们身体所有细胞中的微小细胞器。它们控制许多重要的细胞过程,包括能量产生、脂肪代谢、类固醇合成和程序性细胞死亡。最近,多项研究表明,遗传性或获得性线粒体功能障碍可导致一系列罕见的代谢紊乱以及许多常见疾病,包括 2 型糖尿病、心力衰竭、神经退行性变和衰老过程本身。线粒体是复杂的结构,由大约 1500 种蛋白质组成。这些蛋白质大部分在细胞核中编码,在细胞质中产生,然后输入线粒体中。目前,我们只知道大约 1500 种线粒体蛋白中的 750 种。由于线粒体会导致许多罕见和常见的人类疾病,因此系统地识别构成该细胞器的所有蛋白质并开始了解它们如何在健康和疾病中共同发挥作用非常重要。完整的哺乳动物基因组序列的可用性,结合新的蛋白质检测和显微镜技术,现在提供了一个特殊的机会,可以系统地、全面地识别哺乳动物线粒体的所有蛋白质成分,以及它们如何共同发挥作用。在当前的应用中,我们建议使用融合蛋白质生物化学、计算基因组学和成像的多学科方法来构建哺乳动物线粒体的蛋白质部分列表。该项目将为线粒体功能的系统方法提供重要基础,这在未来几年将极其重要,因为我们将其活动与常见的人类疾病(例如 2 型糖尿病)联系起来。此外,我们生成的蛋白质目录将立即提供罕见线粒体疾病候选疾病基因的丰富来源。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vamsi Krishna Mootha其他文献

Vamsi Krishna Mootha的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vamsi Krishna Mootha', 18)}}的其他基金

Preventing and reversing mitochondrial Leigh syndrome with hypoxia
预防和逆转缺氧线粒体利氏综合征
  • 批准号:
    10544012
  • 财政年份:
    2022
  • 资助金额:
    $ 47.09万
  • 项目类别:
Preventing and reversing mitochondrial Leigh syndrome with hypoxia
预防和逆转缺氧线粒体利氏综合征
  • 批准号:
    10337378
  • 财政年份:
    2022
  • 资助金额:
    $ 47.09万
  • 项目类别:
Mitochondrial Parts, Pathways, and Pathogenesis
线粒体部分、途径和发病机制
  • 批准号:
    9912169
  • 财政年份:
    2017
  • 资助金额:
    $ 47.09万
  • 项目类别:
Mitochondrial Parts, Pathways, and Pathogenesis
线粒体部分、途径和发病机制
  • 批准号:
    9492585
  • 财政年份:
    2017
  • 资助金额:
    $ 47.09万
  • 项目类别:
Human Mitochondrial Disease: From Novel Gene Variants to Causality and Function
人类线粒体疾病:从新基因变异到因果关系和功能
  • 批准号:
    8280338
  • 财政年份:
    2011
  • 资助金额:
    $ 47.09万
  • 项目类别:
Molecular prostheses for mitochondrial disorders
用于线粒体疾病的分子假体
  • 批准号:
    8338836
  • 财政年份:
    2011
  • 资助金额:
    $ 47.09万
  • 项目类别:
Molecular prostheses for mitochondrial disorders
用于线粒体疾病的分子假体
  • 批准号:
    8535179
  • 财政年份:
    2011
  • 资助金额:
    $ 47.09万
  • 项目类别:
Human Mitochondrial Disease: From Novel Gene Variants to Causality and Function
人类线粒体疾病:从新基因变异到因果关系和功能
  • 批准号:
    8664888
  • 财政年份:
    2011
  • 资助金额:
    $ 47.09万
  • 项目类别:
Molecular prostheses for mitochondrial disorders
用于线粒体疾病的分子假体
  • 批准号:
    8724520
  • 财政年份:
    2011
  • 资助金额:
    $ 47.09万
  • 项目类别:
Human Mitochondrial Disease: From Novel Gene Variants to Causality and Function
人类线粒体疾病:从新基因变异到因果关系和功能
  • 批准号:
    8083807
  • 财政年份:
    2011
  • 资助金额:
    $ 47.09万
  • 项目类别:

相似海外基金

Endogenous retrovirus in joint aging and osteoarthritis development
内源性逆转录病毒在关节衰老和骨关节炎发展中的作用
  • 批准号:
    10719364
  • 财政年份:
    2023
  • 资助金额:
    $ 47.09万
  • 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
  • 批准号:
    10717111
  • 财政年份:
    2023
  • 资助金额:
    $ 47.09万
  • 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
  • 批准号:
    10696538
  • 财政年份:
    2023
  • 资助金额:
    $ 47.09万
  • 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
  • 批准号:
    10678789
  • 财政年份:
    2023
  • 资助金额:
    $ 47.09万
  • 项目类别:
Steroid Hormone Pathways Regulating BPH and LUTS
调节 BPH 和 LUTS 的类固醇激素途径
  • 批准号:
    10601867
  • 财政年份:
    2023
  • 资助金额:
    $ 47.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了